PHARMA
SciClone Licenses Chronic Heart Failure Drug From Zensun
SciClone Pharma has licensed from Zensun (Shanghai) Science & Technology Co. Ltd. its chronic heart failure drug, Neucardin.
H1N1 Influenza Vaccine From A*STAR & Cytos Enters Phase I Trials
Singapore's A*STAR and Switzerland's Cytos Biotechnology AG today announced the initiation of Phase I trials for their H1N1 influenza vaccine candidate.
ScinoPharm, Coland Holdings To Co-Develop Generic Oncologic Drugs
ScinoPharm Taiwan Ltd. and Coland Holdings Ltd. announced this week a strategic alliance to develop a series of generic oncological drugs for Mainland China.
Sagent Pharma To Acquire Remaining Interest In Chengdu Kanghong Pharma
U.S. biotech Sagent Pharma will acquire the remaining 50 percent interest of the Kanghong Sagent (Chengdu) Pharmaceutical Corporation Limited joint venture.
A*STAR, Oxford Biodynamics Partner On Stem Cell Research
A*STAR and Oxford Biodynamics have agreed to collaborate on a project to identify epigenetic signatures in stem cells.
Huahai, Oncobiologics Partner On Biosimilar Monoclonal Antibodies
Oncobiologics, Inc. and Zhejiang Huahai Pharmaceutical Co., Ltd have agreed to jointly develop, manufacture, and commercialize biosimilar monoclonal antibody products.
Glaxo & Taiwan’s NRPB Sign Clinical Trial Research Pact
Taiwan's National Research Program for Biopharmaceuticals signed yesterday an MOU with GlaxoSmithKline to develop Taiwan as a clinical trial hub in Asia.
Eisai To Open New Plant In Suzhou, China
Eisai Co., Ltd. will open a new plant at the Suzhou Industrial Park in Suzhou, Jiangsu, China in the first quarter of 2014.
Roche, Ascletis To Bring Hepatitis C Drug Danoprevir Into China
Roche and Ascletis have entered into a collaboration to develop and commercialize Roche's investigational Hepatitis C drug danoprevir in China.
